Evidence map›Paper›PMID 34702761›Full record

ArticleImmunoHorizons2021

Autoimmunity Increases Susceptibility to and Mortality from Sepsis.

Isaac J Jensen, Samantha N Jensen, Patrick W McGonagill, Thomas S Griffith, Ashutosh K Mangalam, Vladimir P Badovinac

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. [Pathophysiologically complex bilateral profound sensorineural hearing loss in the setting of type 2 diabetes mellitus and fungal sepsis: a case report].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Isaac J JensenInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.ORCID 0000-0002-3107-3961
Samantha N JensenInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.
Patrick W McGonagillDepartment of Surgery, University of Iowa, Iowa City, IA.
Thomas S GriffithMicrobiology, Immunology, and Cancer Biology Ph.D. Program, University of Minnesota, Minneapolis, MN.ORCID 0000-0002-7205-9859
Ashutosh K MangalamInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA.ORCID 0000-0002-9926-2531
Vladimir P BadovinacInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA; vladimir-badovinac@uiowa.edu.ORCID 0000-0003-3180-2439
University of Iowa · USUniversity of Minnesota · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
The University of Iowa Clinical and Translational Science AwardUL1TR002537 · NCATS · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R, WINOKUR, PATRICIA · 2018 to 2022
$20.0M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Memory CD8 T cell localization and protection from influenzaR01AI114543 · NIAID · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P, HARTY, JOHN T · 2015 to 2024
$4.4M
CD4 T cell dysregulation and reprogramming in sepsisR35GM140881 · NIGMS · UNIVERSITY OF MINNESOTA · PI Thomas S Griffith · 2021 to 2026
$2.4M
Linking diet, gut microbiota and autoimmune disease: Bacteria induced phytoestrogen metabolites impact immune function in Experimental Autoimmune EncephalitisR01AI137075 · NIAID · UNIVERSITY OF IOWA · PI MANGALAM, ASHUTOSH KUMAR · 2018 to 2022
$2.0M
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses stateR35GM134880 · NIGMS · UNIVERSITY OF IOWA · PI BADOVINAC, VLADIMIR P · 2020 to 2024
$1.9M
Alterations in CD4 T cells during sepsisR01GM115462 · NIGMS · UNIVERSITY OF MINNESOTA · PI GRIFFITH, THOMAS S · 2016 to 2019
$1.2M
BLRD VA I01 BX001324NCATS NIH HHS UL1 TR002537NIAID NIH HHS R01 AI114543NIAID NIH HHS R01 AI137075NIAID NIH HHS T32 AI007485NIAID NIH HHS T32 AI007511NIEHS NIH HHS P30 ES005605NIGMS NIH HHS R01 GM115462NIGMS NIH HHS R35 GM134880NIGMS NIH HHS R35 GM140881
6 · The paper itself

Abstract

We recently demonstrated how sepsis influences the subsequent development of experimental autoimmune encephalomyelitis (EAE) presented a conceptual advance in understanding the postsepsis chronic immunoparalysis state. However, the reverse scenario (autoimmunity prior to sepsis) defines a high-risk patient population whose susceptibility to sepsis remains poorly defined. In this study, we present a retrospective analysis of University of Iowa Hospital and Clinics patients demonstrating increased sepsis prevalence among multiple sclerosis (MS), relative to non-MS, patients. To interrogate how autoimmune disease influences host susceptibility to sepsis, well-established murine models of MS and sepsis and EAE and cecal ligation and puncture, respectively, were used. EAE, relative to non-EAE, mice were highly susceptible to sepsis-induced mortality with elevated cytokine storms. These results were further recapitulated in LPS and

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsDatasets as TopicDisease SusceptibilityEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMaleMiceMiddle AgedMultiple SclerosisPneumococcal InfectionsPrevalence

Identifiers

PMID34702761
PMCPMC9036850
OpenAlexW3208256662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.